National Institute of Arthritis and Musculoskeletal and Skin Diseases, Arthritis Foundation introduce pediatric rheumatic diseases CD-ROM

November 14, 2005

NIAMS, Arthritis Foundation Introduce Pediatric Rheumatic Diseases CD-ROM The National Institute of Arthritis and Musculoskeletal and Skin Diseaseas (NIAMS), a part of the National Institutes of Health, in partnership with the Arthritis Foundation, announces the launch of the Pediatric Rheumatic Diseases CD-ROM and Other Related Information for You and Your Patients, a comprehensive and cost-effective educational and informational tool for doctors and other health professionals who treat children with pediatric rheumatic diseases and related conditions.

Rheumatic diseases are a group of disorders of the joints and soft tissues, causing pain and, in many cases, physical disability. While they affect people of all ages, their impact can be especially profound in children. Collectively, they are among the most common and chronic conditions of childhood. Although we have much to learn about the causes, risk factors, treatment and prevention of these diseases in children, important information already exists.

"There are unique challenges that the rheumatic diseases present in children," says NIAMS Director Stephen I. Katz, M.D., Ph.D. "The CD-ROM will provide doctors, as well as nurses and other health professionals, with a wide range of resources and information to help them better understand these diseases and how to manage them."

Resources on this CD-ROM include:In a prelaunch review of the new CD-ROM by a variety of healthcare professionals, reviewers overwhelming approved the content and indicated they intend to read the literature to become better informed, distribute it to patients and families of patients, share it with colleagues, and recommend it to other pediatric healthcare professionals, says Dr. Katz. Overall, the reviewers were also able to easily navigate the CD-ROM.

Although the primary audience of the CD-ROM is pediatric health professionals and Arthritis Foundation chapter staff and volunteers, copies will also be available for parents of children with rheumatic diseases, primary and secondary school teachers and counselors, faculty at health professions schools and nonprofit organizations serving individuals and families with rheumatic diseases.

"The welfare and care of children with rheumatic diseases is a priority for the Arthritis Foundation," says John H. Klippel, M.D., Arthritis Foundation president and CEO. "We are pleased to collaborate with NIAMS to develop a product that will help health care professionals better understand these diseases in children and, thus, better enable them to provide children with rheumatic diseases the help they need."
-end-
To order a free copy of the CD-ROM, contact the NIAMS Clearinghouse at 877-22-NIAMS (877-226-4267) (free of charge), niamsinfo@mail.nih.gov or www.niams.nih.gov.

The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the Department of Health and Human Services' National Institutes of Health, is to support research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. For additional information, call NIAMS' Clearinghouse toll free at 1-877-22-NIAMS, or visit the NIAMS Web site at www.niams.nih.gov.

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary Federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Related Arthritis Articles from Brightsurf:

Physical activity and sleep in adults with arthritis
A new study published in Arthritis Care & Research has examined patterns of 24-hour physical activity and sleep among patients with rheumatoid arthritis, lupus, and knee osteoarthritis.

Is rheumatoid arthritis two different diseases?
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues.

Does the Mediterranean diet protect against rheumatoid arthritis?
Previous research has demonstrated a variety of health benefits associated with the Mediterranean diet, which is rich in olive oil, cereals, fruit and vegetables, fish, and a moderate amount of dairy, meat, and wine.

Reducing corticosteroid use in rheumatoid arthritis
Is the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early discontinuation prevent characteristic side effects?

Psoriasis onset determines if psoriatic arthritis patients develop arthritis or psoriasis first
In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

The ACR and the Arthritis Foundation present new guidelines offering therapeutic approaches and treatment options for juvenile idiopathic arthritis
Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA).

Does alcohol consumption have an effect on arthritis?
Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.

Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.

Which pain medication is safest for arthritis patients?
In a recent Alimentary Pharmacology & Therapeutics study, arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain plus a stomach acid-reducing medicine called esomeprazole had infrequent gastrointestinal side effects.

Read More: Arthritis News and Arthritis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.